These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36098769)

  • 21. Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE).
    Mageau A; Ferré VM; Goulenok T; Charpentier C; Delory N; Francois C; Houhou-Fidouh N; Papo T; Descamps D; Sacre K
    Ann Rheum Dis; 2022 Aug; 81(8):1194-1196. PubMed ID: 35396228
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New-onset acute psychosis as a manifestation of lupus cerebritis following concomitant COVID-19 infection and vaccination: a rare case report.
    Fekih-Romdhane F; Ghrissi F; Hallit S; Cheour M
    BMC Psychiatry; 2023 Jun; 23(1):419. PubMed ID: 37308940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
    Ma M; Santosa A; Fong W; Chew LC; Low AH; Law A; Poh YJ; Yeo SI; Leung YY; Ng VW; Koh JZ; Tay SH; Mak A; Teng GG; Xu C; Tang JG; Kong KO; Angkodjojo S; Goh WR; Chuah TY; Roslan NE; Arkachaisri T; Teh KL; Sriranganathan M; Tan TC; Phang KF; Yap QV; Chan YH; Cheung PP; Lahiri M
    J Autoimmun; 2023 Jan; 134():102959. PubMed ID: 36473406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of systemic lupus erythematosus after administration of severe acute respiratory syndrome coronavirus 2 vaccine.
    Sakai M; Takao K; Mizuno M; Ando H; Kawashima Y; Kato T; Kubota S; Hirose T; Hirota T; Horikawa Y; Yabe D
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):378-382. PubMed ID: 36715089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune phenomena following SARS-CoV-2 vaccination.
    Ishay Y; Kenig A; Tsemach-Toren T; Amer R; Rubin L; Hershkovitz Y; Kharouf F
    Int Immunopharmacol; 2021 Oct; 99():107970. PubMed ID: 34280851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.
    Akkuzu G; Bes C; Özgür DS; Karaalioğlu B; Mutlu MY; Yıldırım F; Atagündüz P; Gündüz A; Soy M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2143-2151. PubMed ID: 36930514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.
    Moyon Q; Sterlin D; Miyara M; Anna F; Mathian A; Lhote R; Ghillani-Dalbin P; Breillat P; Mudumba S; de Alba S; Cohen-Aubart F; Haroche J; Pha M; Boutin THD; Chaieb H; Flores PM; Charneau P; Gorochov G; Amoura Z
    Ann Rheum Dis; 2022 Apr; 81(4):575-583. PubMed ID: 34607791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of COVID-19 Vaccines in Patients with SLE.
    Tang W; Gartshteyn Y; Ricker E; Inzerillo S; Murray S; Khalili L; Askanase A
    Curr Rheumatol Rep; 2021 Nov; 23(11):79. PubMed ID: 34767100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythema nodosum induced by Covid-19 Pfizer-BioNTech mRNA vaccine: A case report and brief literature review.
    Chahed F; Ben Fadhel N; Ben Romdhane H; Youssef M; Ben Hammouda S; Chaabane A; Aouam K; Ben Fredj N
    Br J Clin Pharmacol; 2023 Feb; 89(2):536-540. PubMed ID: 35434826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech).
    Akiyama Y; Inagaki T; Morioka S; Kusano E; Ohmagari N
    Intern Med; 2023 Jul; 62(13):2013-2017. PubMed ID: 37081683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report.
    Molina-Rios S; Rojas-Martinez R; Estévez-Ramirez GM; Medina YF
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):43-46. PubMed ID: 35246682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Onset Systemic Lupus Erythematosus with Unusual Presentation and Multi-Organ Involvement after Covid-19 Vaccination in a Pediatric Patient: A Case Report.
    Vahedi M; Malek A; Saadat S; Tahghighi Sharabian F; Pourbadakhshan N
    Iran J Kidney Dis; 2024 Oct; 18(5):. PubMed ID: 39423111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
    Naveen R; Thakare DR; Kuwana M; Pauling JD; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; ; Aggarwal R; Gupta L; Agarwal V; Makol A
    Rheumatol Int; 2023 Jul; 43(7):1265-1275. PubMed ID: 37000295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
    Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity-related neutrophilic dermatosis after coronavirus disease 2019 vaccination: A case report and literature review.
    Kishibe M; Koike K; Kanno K; Ishida-Yamamoto A
    J Dermatol; 2023 Jun; 50(6):820-823. PubMed ID: 36606292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies.
    Heil M
    Front Immunol; 2023; 14():1259879. PubMed ID: 38439942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.
    Niebel D; Ralser-Isselstein V; Jaschke K; Braegelmann C; Bieber T; Wenzel J
    Dermatol Ther; 2021 Jul; 34(4):e15017. PubMed ID: 34075664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.